Amino Collective

Rematiq operates as an AI-native platform for automated product compliance in the medical technology sector.

Nine self contained Environmental Sensors monitor conditions related to building spaces and equipment Cloud Based Analytics turns that sensor data Into real time alerts and other actionable intelligence. Open platform designed to integrate with other sensors and data sources, and combine their output at the analytical stage to create more refined intelligence.

ExpressionEdits is a biotechnology company focused on enhancing synthetic DNA instructions to improve protein expression. Utilizing an AI-driven research platform, the company aims to transform existing methodologies for transgene expression in mammalian systems, thereby increasing the yields, quality, and efficacy of recombinant proteins and DNA medicines. The team comprises scientists and engineers committed to advancing technologies that mimic natural biological processes. By addressing fundamental challenges in protein expression, ExpressionEdits plays a significant role in supporting research and development in healthcare and synthetic biology.

Anima is an advanced clinical operating system designed to streamline patient care for healthcare teams. The platform facilitates online consultations and provides features such as comprehensive patient history tracking, one-click coding for record-keeping, and automated patient communications. It also includes tools for managing limited assignments and patient access, as well as integrated email and SMS messaging for enhanced communication. Anima is fully compatible with electronic health records (EHR), enabling the automatic generation, coding, and saving of clinical notes directly to the patient's record. This integration allows care teams to deliver optimal care plans efficiently and effectively.

Biomia is a synthetic biology company that focuses on developing plant-derived natural products aimed at addressing unmet medical needs related to pain, addiction, and depression. The company utilizes a drug discovery engine that integrates machine learning and biosynthesis to identify and create therapeutics based on plant-inspired molecules. Through pre-clinical testing, Biomia works on developing both natural and novel small-molecule drug candidates, with the goal of providing effective treatments for patients suffering from various mental health issues.

Lindus Health is a clinical research organization focused on delivering comprehensive clinical trial services for health and biotech companies. The company offers a range of solutions, including ethics and IRB submission, trial monitoring, data management, biostatistics, regulatory support, and payer affairs. By utilizing a proprietary software platform, Lindus Health automates various aspects of the clinical trial workflow, which streamlines operations and minimizes manual inefficiencies. This platform also facilitates access to electronic health records, enhancing patient recruitment and clinical data capture. Furthermore, Lindus Health leverages real-world patient data to improve trial design and execution, ultimately aiming to accelerate the clinical trial process while reducing risks and costs associated with trial failures.

Operator of a cell-based biotechnology platform designed to produce messenger ribonucleic acid(mRNA) therapeutics and vaccines. The company's platform uses cell engineering, computational biology, and precision fermentation to optimize the production of vaccinia capping enzymes, enabling medical professionals to provide optimal medicines to their patients.

Seqera develops workflow orchestration software aimed at simplifying complex data analysis for life sciences research. The company's platform consolidates fragmented data and diverse computing resources, enabling scientists to create and deploy scalable data analysis pipelines in multi-cloud environments with ease. By empowering researchers with modern software tools, Seqera enhances productivity and accelerates scientific discovery across fields such as genomics and global health. Trusted by over 150 leading life science organizations, Seqera's solutions facilitate faster and more confident scientific inquiry, supporting innovation and collaboration in an increasingly data-driven world.

Hedera Dx is a healthcare venture based in Epalinges, Vaud, established on July 1, 2021, that develops a liquid biopsy solution aimed at simplifying tumor profiling for hospital labs. This technology provides clinicians with a streamlined experience for accessing information and conducting liquid biopsy tests, which are essential for early cancer detection, therapy selection, and monitoring recurrence. By addressing challenges such as IVD compliance, privacy infrastructure, and validation, Hedera Dx enhances the efficiency of existing software workflows while offering key capabilities that were previously lacking. The company's innovations provide medical professionals with new opportunities to reduce cancer mortality and healthcare costs.

Kernal Biologics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on designing and developing mRNA immunotherapies for diseases such as COVID-19 and cancer. Founded in 2016, the company utilizes its mRNA platform to enable specific cells to produce their own therapeutic agents. Kernal's innovative approach has garnered recognition, including awards from notable organizations like Amgen and NASA. The team behind Kernal Biologics has strong ties to prestigious institutions such as MIT and Harvard, along with extensive experience in the biotech sector, which underpins their expertise in the mRNA field.

Aware is a company that develops a mobile application focused on evaluating health data and researching chronic diseases. The app enables users to check and track their health conditions, offering insights into their well-being. Aware also provides blood tests through a subscription model, enhancing the service by allowing clients to gain a deeper understanding of their health status. By leveraging data, Aware empowers individuals to take control of their health and make informed decisions regarding their well-being.

Junction (formerly Vital) allows developers to access health data from wearable devices and at-home test kits. The company was founded in 2021 by Maitham Dib and is headquartered in San Francisco, California, United States.

Kano Therapeutics specializes in advancing gene-editing therapies through the development of innovative biomaterials. The company utilizes circular single-stranded DNA biomaterials to create a comprehensive platform that integrates manufacturing, application, and computational tools for genetic payload development. By harnessing DNA nanotechnology and synthetic biology, Kano Therapeutics designs and engineers novel gene vectors that facilitate the safe and effective delivery of genetic information. This platform supports researchers and organizations in their pursuit of genetic cures and enhances the capabilities of pharmaceutical and synthetic biology companies in gene delivery and vaccine development.

Vira Health is a digital health company dedicated to enhancing long-term health outcomes for women by focusing on female-specific conditions. It specializes in developing digital therapeutics that provide evidence-based interventions for managing menopause symptoms, including insomnia, anxiety, depression, hot flushes, weight gain, and incontinence. Vira's approach emphasizes personalized care and tailored treatments, which not only assist women in coping with the complexities of menopause but also aim to delay the onset of chronic conditions such as osteoporosis, cardiovascular disease, and dementia. Through improved collection and utilization of female health data, Vira Health seeks to address the unique healthcare needs of women and promote better health management throughout their lives.

Nostos Genomics collaborates with genetic testing laboratories to enhance the diagnosis of genetic diseases. The company has developed a platform that integrates machine learning and synthetic biology, enabling laboratories to utilize a proprietary algorithm that identifies likely pathogenic variants. This technology improves diagnostic yield, accelerates the interpretation of genetic variants, and allows labs to focus on complex cases. By streamlining these processes, Nostos Genomics aims to provide clearer and faster diagnoses for individuals affected by genetic disorders, thereby supporting the growth of sustainable operations within genetic testing laboratories.

Kenbi is a nurse-centric outpatient care company focused on enhancing healthcare delivery by supporting nurses and addressing gaps in the system. It offers outpatient care management services that leverage technology and a collegial organizational structure to organize local care teams. These teams provide at-home services, which may include medical care covered by insurance, household assistance, advice, and companionship. By streamlining operations and reducing bureaucratic burdens, Kenbi enables healthcare practitioners to devote more time to patient care, thus improving the overall experience for patients and their families.

Aware is a company that develops a mobile application focused on evaluating health data and researching chronic diseases. The app enables users to check and track their health conditions, offering insights into their well-being. Aware also provides blood tests through a subscription model, enhancing the service by allowing clients to gain a deeper understanding of their health status. By leveraging data, Aware empowers individuals to take control of their health and make informed decisions regarding their well-being.

Lindus Health is a clinical research organization focused on delivering comprehensive clinical trial services for health and biotech companies. The company offers a range of solutions, including ethics and IRB submission, trial monitoring, data management, biostatistics, regulatory support, and payer affairs. By utilizing a proprietary software platform, Lindus Health automates various aspects of the clinical trial workflow, which streamlines operations and minimizes manual inefficiencies. This platform also facilitates access to electronic health records, enhancing patient recruitment and clinical data capture. Furthermore, Lindus Health leverages real-world patient data to improve trial design and execution, ultimately aiming to accelerate the clinical trial process while reducing risks and costs associated with trial failures.

Seqera develops workflow orchestration software aimed at simplifying complex data analysis for life sciences research. The company's platform consolidates fragmented data and diverse computing resources, enabling scientists to create and deploy scalable data analysis pipelines in multi-cloud environments with ease. By empowering researchers with modern software tools, Seqera enhances productivity and accelerates scientific discovery across fields such as genomics and global health. Trusted by over 150 leading life science organizations, Seqera's solutions facilitate faster and more confident scientific inquiry, supporting innovation and collaboration in an increasingly data-driven world.

Vira Health is a digital health company dedicated to enhancing long-term health outcomes for women by focusing on female-specific conditions. It specializes in developing digital therapeutics that provide evidence-based interventions for managing menopause symptoms, including insomnia, anxiety, depression, hot flushes, weight gain, and incontinence. Vira's approach emphasizes personalized care and tailored treatments, which not only assist women in coping with the complexities of menopause but also aim to delay the onset of chronic conditions such as osteoporosis, cardiovascular disease, and dementia. Through improved collection and utilization of female health data, Vira Health seeks to address the unique healthcare needs of women and promote better health management throughout their lives.

NuvoAir AB, founded in 2015 and based in Stockholm, Sweden, is a medical technology company focused on monitoring lung function through its Air Next home spirometer. The company operates an online platform to provide its products and services. NuvoAir Medical offers a comprehensive care model that integrates advanced monitoring technology and analytics with evidence-based interventions for managing chronic heart and lung conditions. This approach emphasizes personalized care, delivered by a multidisciplinary team, and collaborates with health plans and risk-bearing entities to implement flexible payment arrangements. By focusing on value-based specialty management, NuvoAir aims to improve patient outcomes while reducing healthcare costs.

Anima is an advanced clinical operating system designed to streamline patient care for healthcare teams. The platform facilitates online consultations and provides features such as comprehensive patient history tracking, one-click coding for record-keeping, and automated patient communications. It also includes tools for managing limited assignments and patient access, as well as integrated email and SMS messaging for enhanced communication. Anima is fully compatible with electronic health records (EHR), enabling the automatic generation, coding, and saving of clinical notes directly to the patient's record. This integration allows care teams to deliver optimal care plans efficiently and effectively.

Anima is an advanced clinical operating system designed to streamline patient care for healthcare teams. The platform facilitates online consultations and provides features such as comprehensive patient history tracking, one-click coding for record-keeping, and automated patient communications. It also includes tools for managing limited assignments and patient access, as well as integrated email and SMS messaging for enhanced communication. Anima is fully compatible with electronic health records (EHR), enabling the automatic generation, coding, and saving of clinical notes directly to the patient's record. This integration allows care teams to deliver optimal care plans efficiently and effectively.

Kenbi is a nurse-centric outpatient care company focused on enhancing healthcare delivery by supporting nurses and addressing gaps in the system. It offers outpatient care management services that leverage technology and a collegial organizational structure to organize local care teams. These teams provide at-home services, which may include medical care covered by insurance, household assistance, advice, and companionship. By streamlining operations and reducing bureaucratic burdens, Kenbi enables healthcare practitioners to devote more time to patient care, thus improving the overall experience for patients and their families.

Awell Health is a healthcare technology company that focuses on enhancing patient outcomes by streamlining clinical workflows and care pathways. The platform is designed to integrate seamlessly into the existing technology stack of healthcare organizations, allowing them to create, implement, and update care pathways effectively. Awell Health's cloud-based service automates routine clinical tasks, synchronizes data across systems, and fosters coordination between care teams and patients. By shifting the emphasis from merely collecting data to reorganizing fragmented and paper-based processes, Awell Health aims to support healthcare providers in making informed decisions at every stage of the patient care journey.

Allcyte is a biotechnology start-up specializing in functional drug testing using primary human material. The company has developed a high-content imaging platform that analyzes drug action at a single-cell level, closely simulating in vivo conditions. This approach allows for precise evaluation of how cancer treatments may perform in real patients. By employing advanced image analysis and machine learning techniques, Allcyte generates actionable insights that assist physicians and pharmaceutical companies in prioritizing drug development efforts and treatment decisions. The company aims to facilitate personalized medicine for cancer patients, ensuring that the right therapies are matched to the right individuals.

Nostos Genomics collaborates with genetic testing laboratories to enhance the diagnosis of genetic diseases. The company has developed a platform that integrates machine learning and synthetic biology, enabling laboratories to utilize a proprietary algorithm that identifies likely pathogenic variants. This technology improves diagnostic yield, accelerates the interpretation of genetic variants, and allows labs to focus on complex cases. By streamlining these processes, Nostos Genomics aims to provide clearer and faster diagnoses for individuals affected by genetic disorders, thereby supporting the growth of sustainable operations within genetic testing laboratories.

Seqera develops workflow orchestration software aimed at simplifying complex data analysis for life sciences research. The company's platform consolidates fragmented data and diverse computing resources, enabling scientists to create and deploy scalable data analysis pipelines in multi-cloud environments with ease. By empowering researchers with modern software tools, Seqera enhances productivity and accelerates scientific discovery across fields such as genomics and global health. Trusted by over 150 leading life science organizations, Seqera's solutions facilitate faster and more confident scientific inquiry, supporting innovation and collaboration in an increasingly data-driven world.

Hedera Dx is a healthcare venture based in Epalinges, Vaud, established on July 1, 2021, that develops a liquid biopsy solution aimed at simplifying tumor profiling for hospital labs. This technology provides clinicians with a streamlined experience for accessing information and conducting liquid biopsy tests, which are essential for early cancer detection, therapy selection, and monitoring recurrence. By addressing challenges such as IVD compliance, privacy infrastructure, and validation, Hedera Dx enhances the efficiency of existing software workflows while offering key capabilities that were previously lacking. The company's innovations provide medical professionals with new opportunities to reduce cancer mortality and healthcare costs.

Inductive Bio specializes in providing a machine learning platform that enhances the compound optimization process for drug development. The company focuses on addressing ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) challenges by building comprehensive datasets and machine learning models. This enables scientists to efficiently identify and refine small molecule compounds, transforming initial candidates into viable leads more rapidly and with improved properties. By streamlining the optimization process, Inductive Bio supports the development of new therapeutics, ultimately contributing to advancements in the pharmaceutical industry.